Highlights
KLSE: INIX (0094)       INIX TECHNOLOGIES HOLDINGS BHD ACE : Technology
Last Price Today's Change   Day's Range   Trading Volume
0.315   -0.015 (4.55%)  0.31 - 0.33  22,621,700
Trade this stock and win a FREE I3investor T-shirt after 5 trades. Find out more.

Financials


Market Cap: 147 Million

Market Cap 147 Million
NOSH 467 Million

Latest Audited Result:  31-Jan-2020

Latest Audited Result: 31-Jan-2020
Announcement Date 30-Jun-2020
Next Audited Result: 31-Jan-2021
Est. Ann. Date: 30-Jun-2021
Est. Ann. Due Date: 30-Jul-2021

Latest Quarter:  31-Oct-2020 [#3]

Latest Quarter: 31-Oct-2020 [#3]
Announcement Date 28-Dec-2020
Next Quarter: 31-Jan-2021
Est. Ann. Date: 19-May-2021
Est. Ann. Due Date: 01-Apr-2021
QoQ | YoY   -475.46%  |    -581.51%

Annual (Unaudited) ( EPS: -0.59, P/E: -53.68 )

Revenue | NP to SH 8,049  |  -2,738
RPS | P/RPS 1.73 Cent  |  18.26
EPS | P/E | EY -0.59 Cent  |  -53.68  |  -1.86%
DPS | DY | Payout % 0.00 Cent  |  0.00%  |  - %
NAPS | P/NAPS 0.05  |  6.26
YoY   82.14%
NP Margin | ROE -41.73%  |  -11.66%
F.Y. | Ann. Date 31-Jan-2020  |  19-May-2020

T4Q Result ( EPS: 0.46, P/E: 69.04 )

Revenue | NP to SH 3,638  |  2,129
RPS | P/RPS 0.78 Cent  |  40.40
EPS | P/E | EY 0.46 Cent  |  69.04  |  1.45%
DPS | DY | Payout % 0.00 Cent  |  0.00%  |  - %
NAPS | P/NAPS 0.08  |  4.03
QoQ | YoY   -24.53%  |    143.87%
NP Margin | ROE 41.15%  |  5.83%
F.Y. | Ann. Date 31-Oct-2020  |  28-Dec-2020

Annualized Result ( EPS: -0.28, P/E: -113.18 )

Revenue | NP to SH 2,694  |  -1,298
RPS | P/RPS 0.58 Cent  |  54.54
EPS | P/E | EY -0.28 Cent  |  -113.18  |  -0.88%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   -113.60%  |    73.94%
NP Margin | ROE -55.86%  |  -3.56%
F.Y. | Ann. Date 31-Oct-2020  |  28-Dec-2020



Business Performance

Business Performance (By Quarter)

Trailing 4 Quarters Trailing 8 Quarters
Available Quarters 4 Quarters 8 Quarters
Continuous Quarters Of Revenue Growth 1 / 4 25.00% 1 / 8 12.50%
Total Positive Profit Years 2 / 4 50.00% 3 / 8 37.50%
Continuous Quarters Of Positive Profit 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Profit Growth 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Adjusted EPS Growth 0 / 4 0.00% 0 / 8 0.00%
Total Dividend Years 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Dividend 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Dividend Growth 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Adjusted Dps Growth 0 / 4 0.00% 0 / 8 0.00%
Average ROE 2.58% -1.83%
Average Net Profit Margin -4.22% -51.97%

Business Performance (By Year)

Last 5 Financial Years Last 10 Financial Years
Available Years 5 Years 10 Years
Continuous Years Of Revenue Growth 1 / 5 20.00% 1 / 10 10.00%
Total Positive Profit Years 0 / 5 0.00% 2 / 10 20.00%
Continuous Years Of Positive Profit 0 / 5 0.00% 0 / 10 0.00%
Continuous Years Of Profit Growth 3 / 5 60.00% 3 / 10 30.00%
Continuous Years Of Adjusted EPS Growth 3 / 5 60.00% 3 / 10 30.00%
Total Dividend Years 0 / 5 0.00% 0 / 10 0.00%
Continuous Years Of Dividend 0 / 5 0.00% 0 / 10 0.00%
Continuous Years Of Dividend Growth 0 / 5 0.00% 0 / 10 0.00%
Continuous Years Of Adjusted Dps Growth 0 / 5 0.00% 0 / 10 0.00%
Average ROE -99.73% -52.93%
Average Net Profit Margin -134.11% -82.13%

Key Result

Key Result

T4Q Annualized Annual (Unaudited) Last 10 FY Average Last 5 FY Average
Revenue 3,638 2,694 8,049 6,122 7,490
NP to SH 2,129 -1,298 -2,738 -5,468 -9,750
Dividend 0 - - - -
Adjusted EPS 0.46 -0.28 -0.59 -1.17 -2.09
Adjusted DPS 0.00 0.00 0.00 - -

NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share

All figures in '000 unless specified.

EPS & DPS's figures in Cent.


Growth

Growth (By Quarter)

LQ QoQ LQ YoY CQ YoY LQ vs Average of T4Q LQ vs Average of T8Q
Revenue 21.14% -34.08% -68.58% -16.22% -29.51%
NP to Owner -475.46% -581.51% 83.25% -252.37% -138.18%
Dividend 0.00% 0.00% 0.00% 0.00% 0.00%
Adj. EPS -475.46% -581.51% 83.25% -252.37% -138.18%
Adj. DPS 0.00% 0.00% 0.00% 0.00% 0.00%

LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year

Growth (By Year)

T4Q vs LFY T4Q vs AL5FY T4Q vs AL10FY AQR vs LFY AQR vs AL5FY AQR vs AL10FY LFY YoY LFY vs AL5FY LFY vs AL10FY
Revenue -54.80% -51.43% -40.58% -66.52% -64.03% -55.98% -14.81% 7.45% 31.47%
NP to Owner 177.76% 121.83% 138.93% 52.57% 86.68% 76.25% 82.14% 71.92% 49.93%
Dividend 0.00% 0.00% 0.00% - % - % - % 0.00% 0.00% 0.00%
Adj. EPS 177.76% 121.83% 138.93% 52.57% 86.68% 76.25% 82.14% 71.92% 49.93%
Adj. DPS 0.00% 0.00% 0.00% - % - % - % 0.00% 0.00% 0.00%

T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year

Analyze this stock with MQ Trader system
  13 people like this.
 
Manggalee https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3123537
23/01/2021 1:06 PM
Manggalee going to down some more?
23/01/2021 1:11 PM
ruby20 goreng stock. avoid. wanna buy glove shares buy first tier.

wanna buy glove wannabe buy iconic
23/01/2021 1:15 PM
DLLM99_kyy Big Con Man Tan Soon Hwa !
23/01/2021 2:01 PM
STEADYBOMBIBI85 No official agreement or mou to distribute the vaccines for general public. Inix is only distributing the vaccines for clinical trial only. Part of their CSR initiative.
23/01/2021 3:51 PM
Dankot Glove manufacturing is on or not...now oso want to distribute the vaccine is real or not....
23/01/2021 4:48 PM
MadCow75 sorry.. what i understand only helping to source china vaccine... so everyone had own understanding... just pls read careful the notice...
23/01/2021 4:49 PM
YuHainTeck Be patience. Will fly high once get approval from NPRA. Query from Bursa already answered.
23/01/2021 9:26 PM
shadowz Glove production line started, going to increase every months, this counters is no more pure speculative but with strong earning prospects. And being a goreng stock is actually a surplus point to enter, better than those sleeping counter right...who knows next day it hits limit up again ler hahaha...
23/01/2021 11:01 PM
STEADYBOMBIBI85 yea yea approval to import the vaccine for clinical trial LOL
23/01/2021 11:15 PM
STEADYBOMBIBI85 Its not approval for marketing lol
23/01/2021 11:15 PM
SamChong Naive
23/01/2021 11:47 PM
STEADYBOMBIBI85 Its stated clearly in the first announcement if you bother to read until the end
24/01/2021 12:39 AM
zalmiez82 SteDybombibi85- please be positive la...be matured and profesional
24/01/2021 7:33 AM
Miz Raya Bloom nengok ler sebelum thaipusam apa jadi
24/01/2021 2:07 PM
Wanamakemoney Slowly but surely. For trial 1st then distribute la.nobody wanting to do a donkey job.
24/01/2021 7:25 PM
MadCow75 sorry.. im not negative person... i think bombibi still not so rite.. coz is write there help to source.. then mention few china vaccine... but china got so many lab research for covid vaccine... i dun think to help bring in for trial... is help to source only...
24/01/2021 10:09 PM
dragon_loong Please read the whole announcement carefully until the end.
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3123537

Reference is made to the Company’s announcement made on 13 January 2021 and 20 January 2021.

For clarification, the Board of Directors of INIX wishes to inform that Inix Network Sdn Bhd was appointed as distributors for the Covid-19 vaccine by Sinovac Biotech Co Ltd, Cansino Biologics Inc and Sinopharm China National Biotech Group Co Ltd on 28 October 2020.

This announcement is dated 22 January 2021.
24/01/2021 10:58 PM
char1234 all is good, just wait
24/01/2021 11:00 PM
STEADYBOMBIBI85 @dragon_loong Distribution here refers to distribution of vaccine for clinical trial participants, not distribution of vaccine for general public use. Inix will sponsor the vaccines for use in the clinical trial as part of their CORPORATE SOCIAL RESPONSIBILITY (CSR) INITIATIVE.


Read until the end, especially the last paragrah of the 1st announcement. The hint is there.

“ As and when iNix has received the approval from MoH, iNix would be able to import the vaccine and supply the same to MoH to conduct 3rd Phase Clinical Trial in which it would be fully sponsored by iNix as INIX’s CSR initiative. This first clinical trial in Malaysia is expected to involve approximately 3,000 volunteers.”


The “approval” here refers to the approval to import the vaccine for purpose of clinical trial only and not approval for general public use in Malaysia. Otherwise why do you still need to conduct clinical trials when the approval of the vaccine by MOH is for general public use? Inix is playing around with words here to confuse and mislead the shareholders.

Besides, there is no MOU or official distributor agreement between Sinovac, Cansino and Sinopharm with Inix. Otherwise, it would have been announced in Bursa Malaysia.

https://disclosure.bursamalaysia.com/FileAccess/apbursaweb/download?id=110697&name=EA_GA_ATTACHMENTS
25/01/2021 1:45 AM
zalmiez82 Steadybombibi85 that way i said to you more matured and profesional. Sell vaccine is not like sell goreng pisang. It must goes step by step.
25/01/2021 7:22 AM
char1234 glove counter confirm but all glove counter in correction mode
25/01/2021 7:48 AM
AhSook AhKou BIG Elephant dumping holland shit now ...... oh oh
25/01/2021 9:05 AM
baskoro1965 Big gloves up inix down, big glove down inix more down.
25/01/2021 10:24 AM
25/01/2021 11:27 AM
Valueinvestor mentioned many times, this counter cannot greedy........ must earn that few cent only. the operator TCH not ambitious and focus on small money earn!
25/01/2021 11:34 AM
TomyamGong ice cream already .. this stock being manipulates
25/01/2021 11:53 AM
Briankk Good news also drop.... Hold tight
Drop more so I can buy more...
Hahaha
25/01/2021 3:54 PM
Valueinvestor solution MOU ith cansino...up nicely...
25/01/2021 4:16 PM
STEADYBOMBIBI85 https://www.theedgemarkets.com/article/bioalpha-join-vaccine-distribution-bandwagon
25/01/2021 4:50 PM
STEADYBOMBIBI85 The Board of Directors of Bioalpha Holdings Berhad (“Bioalpha” or “the Company”) wishes to announce that Bioalpha International Sdn. Bhd. (“BISB”), a wholly-owned subsidiary of Bioalpha has on 25 January 2021 entered into a Procurement and Distribution Agreement (“Agreement”) with Shanghai Bukun Trading Co., Ltd (“SBTC”), a wholly-owned subsidiary of Sinopharm (Hainan) Health Industry Co., Ltd (“Sinopharm Hainan”) for the procurement and distribution of vaccines in Malaysia, including but not limited to the Covid-19 vaccine developed by Sinovac Biotech Co., Ltd. (“Sinovac Biotech”), subject to relevant authorities’ approvals which include the National Pharmaceutical Regulatory Agency (“NPRA”). This arrangement has also been endorsed by Sinovac Biotech with regards to the Covid-19 vaccine.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3123824
25/01/2021 4:51 PM
Sneakpeek main activity is tech..

Change chairman thrice in a year

Durian season MOU with durian supplier
Then glove season MOU with glove manufacturer
Then vaccine season MOU with all three China supplier in one go.

hahahahahahah...open your eyes laa the sign so obvious.
25/01/2021 9:59 PM
char1234 fair value now, for glove counter ....
26/01/2021 1:16 AM
TomyamGong Wondering how much profit can they earn from glove?
26/01/2021 1:24 AM
Sneakpeek Go go at least must reach 1.45 today
26/01/2021 9:59 AM
HosehLim80 Holland one way ticket
26/01/2021 10:45 AM
khatulistiwa1234 DIVER LOL 0.25 short ward .
26/01/2021 2:51 PM
STEADYBOMBIBI85 This stock is really goreng con man stock. Stay away.
26/01/2021 3:24 PM
Valueinvestor when dive lower then buy more.. earn 20% not difficult from this counter. die hard fans know well...don keep dream will over 40 cent...
26/01/2021 3:37 PM
khatulistiwa1234 Never to buy , all is cheat and lies .
26/01/2021 4:06 PM
khatulistiwa1234 0.10 chips .
26/01/2021 4:06 PM
BILLC Khatu mari,,,,habissss inixxx,,,,,semua kena kencing lagiiii,,,,,
26/01/2021 4:44 PM
dec_12 Look like is the time to buy in on next week.
Show that is going to 25c soon...
26/01/2021 6:29 PM
Kingston1 Got chance to collect cheap tmr or not? Tan choon hock ? Hahahaha
26/01/2021 9:36 PM
Valueinvestor No more vaccine news.. Pharmaniaga sealed deal for China vaccine.
26/01/2021 9:55 PM
char1234 trading at fair value.....no need speculate
26/01/2021 11:02 PM
char1234 owner now playing with you only ☺️
26/01/2021 11:03 PM
shadowz China & Russia vaccines done deal with Pharma & dpharma liao today , so confirm no chance for inix
26/01/2021 11:39 PM
shadowz https://www.theedgemarkets.com/article/duopharma-signs-deal-putrajaya-supply-russian-covid19-vaccine
26/01/2021 11:40 PM
shadowz https://focusmalaysia.my/markets/pharmaniaga-puts-faith-in-chinese-coronavac-vaccine-supplies-12m-doses-to-moh/
26/01/2021 11:41 PM